Nichola Smith
19Patents
3h-index
51Co-inventors
59Inventor score
Filing activity: Dec 20, 2006 → Jan 13, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11254653B2 | NLRP3 inflammasome inhibitors | Chemistry; Metallurgy | 11 | Active |
| US7803804B2 | Substituted pyrazines for use in the treatment of inflammatory or allergic conditions | Chemistry; Metallurgy | 6 | Active |
| US8039472B2 | Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel | Chemistry; Metallurgy | 6 | Active |
| US9403833B2 | Carboxamide derivatives | Chemistry; Metallurgy | 3 | Active |
| US9403810B2 | Carboxamide derivatives | Chemistry; Metallurgy | 3 | Active |
| US8372845B2 | Pyrazine derivatives as enac blockers | Chemistry; Metallurgy | 2 | Active |
| US11208399B2 | NLRP3 inflammasome inhibitors | Chemistry; Metallurgy | 2 | Active |
| US8318935B2 | Organic compounds 75074 | Human Necessities | 2 | Active |
| US9050339B2 | Pyrazine derivatives as ENaC blockers | Chemistry; Metallurgy | 2 | Active |
| US9139586B2 | Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives | Chemistry; Metallurgy | 2 | Active |
| US8697687B2 | Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives | Chemistry; Metallurgy | 1 | Active |
| US10844055B2 | Naphthyridinone derivatives and their use in the treatment of arrhythmia | Chemistry; Metallurgy | 1 | Active |
| US12139471B2 | NLRP3 inflammasome inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10195181B2 | Carboxamide derivatives | Chemistry; Metallurgy | 0 | Active |
| US11672782B2 | Carboxamide derivatives | Chemistry; Metallurgy | 0 | Active |
| US11530213B2 | Naphthyridinone derivatives and their use in the treatment of arrhythmia | Chemistry; Metallurgy | 0 | Active |
| US9522149B2 | Pyrazine derivatives as ENaC blockers | Chemistry; Metallurgy | 0 | Active |
| US9643983B2 | Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives | Chemistry; Metallurgy | 0 | Active |
| US9931319B2 | Carboxamide derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.